Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,979.73 +4,763.72 (+8.04%) CMC Crypto 200
1,359.39 +82.41 (+6.45%)
AMGN Jan 2025 170.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 10:02AM EDT
| Previous close | 1.2000 |
| Open | 0.6600 |
| Bid | 0.6200 |
| Ask | 0.8000 |
| Strike | 170.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.6600 - 0.8500 |
| Contract range | N/A |
| Volume | |
| Open interest | 279 |
Yahoo FinanceAmgen's peek at its GLP-1 drug trial results heightens competition in obesity market
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
GuruFocus.comDecoding Amgen Inc (AMGN): A Strategic SWOT Insight
Insightful Analysis of Amgen Inc's Strengths, Weaknesses, Opportunities, and Threats
Barrons.comThese Stocks Moved the Most Today: Apple, Amgen, Expedia, Coinbase, Cloudflare, Fortinet, Live Nation, and More
Apple reports better-than-estimated earnings and expands its buyback program by $110 billion, Amgen ‘very encouraged’ by preliminary data from a trial of a weight-loss drug, and Expedia reduces its sales outlook for the year.
© 2024 Yahoo. All rights reserved.